气管切开患者气道全程管理的循证护理实践方案的构建与应用

注册号:

Registration number:

ChiCTR2300067508 

最近更新日期:

Date of Last Refreshed on:

2023-09-12 18:22:38 

注册时间:

Date of Registration:

2023-01-10 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

气管切开患者气道全程管理的循证护理实践方案的构建与应用

Public title:

The construction and application of evidence-based nursing practice plan for the entire airway management of tracheotomy patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

气管切开患者气道全程管理的循证护理实践方案的构建与应用

Scientific title:

The construction and application of evidence-based nursing practice plan for the entire airway management of tracheotomy patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

文辉 

研究负责人:

文辉 

Applicant:

Wen Hui 

Study leader:

Wen Hui 

申请注册联系人电话:

Applicant telephone:

+86 158 7496 6426

研究负责人电话:

Study leader's
telephone:

+86 158 7496 6426

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

642643169@qq.com

研究负责人电子邮件:

Study leader's E-mail:

642643169@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

湖南省长沙市芙蓉区解放西路61号

研究负责人通讯地址:

湖南省长沙市芙蓉区解放西路61号

Applicant address:

61 Jiefang Road West, Furong District, Changsha, Hunan

Study leader's address:

61 Jiefang Road West, Furong District, Changsha, Hunan

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

湖南省人民医院

Applicant's institution:

Hunan Provincial People's Hospital

研究负责人所在单位:

湖南省人民医院

Affiliation of the Leader:

Hunan Provincial People's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

[2022]-89

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

湖南省人民医院伦理委员会

Name of the ethic committee:

Ethics Committee of Hunan Provincial People's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2022-05-18 00:00:00

伦理委员会联系人:

李璟

Contact Name of the ethic committee:

Li Jing

伦理委员会联系地址:

湖南省长沙市芙蓉区解放西路61号

Contact Address of the ethic committee:

61 Jiefang Road West, Furong District, Changsha, Hunan

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

湖南省人民医院

Primary sponsor:

Hunan Provincial People's Hospital

研究实施负责(组长)单位地址:

湖南省长沙市芙蓉区解放西路61号

Primary sponsor's address:

61 Jiefang Road West, Furong District, Changsha, Hunan

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖南

市(区县):

长沙

Country:

China

Province:

Hunan

City:

Changsha

单位(医院):

湖南省人民医院

具体地址:

湖南省长沙市芙蓉区解放西路61号

Institution
hospital:

Hunan Provincial People's Hospital

Address:

61 Jiefang Road West, Furong District, Changsha, Hunan

经费或物资来源:

政府

Source(s) of funding:

Government

研究疾病:

气管切开  

Target disease:

Tracheotomy

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

非随机对照试验 

Study design:

Non randomized control 

研究目的:

1. 构建气切患者全程管理的循证护理实践方案。 2. 将气切患者全程管理的循证护理实践方案应用于临床护理实践。  

Objectives of Study:

1. To construct an evidence-based nursing practice protocol for the full management of tracheotomized patients. 2. Applying the evidence-based nursing practice protocol for the full management of tracheotomized patients to clinical nursing practice.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1. 气管切开前存在气道严重烧伤、气管造口周围皮肤损伤、感染者; 2. 首次住院时外院带入气切导管且合并气道出血、感染、狭窄等相关并发症的患者; 3. 患者或家属拒绝参与研究者。

Exclusion criteria:

1. Those with severe burns of the airway, peri-tracheostomy, or infected skin before tracheotomy skin injury and infection before tracheotomy; 2. Patients who brought in a tracheotomy tube from outside the hospital during their first hospitalization and had a combination of airway bleeding, infection, stenosis, and other related complications of patients; 3. Patients or family members who refused to participate in the research.

研究实施时间:

Study execute time:

From 2023-02-01 00:00:00 To 2023-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-02-01 00:00:00 To 2023-07-31 00:00:00

干预措施:

Interventions:

组别:

常规护理组

样本量:

32

Group:

Routine care group

Sample size:

干预措施:

实施气切术后护理常规和延续护理

干预措施代码:

Intervention:

Implementation of post-tracheotomy care routines and continuity of care

Intervention code:

组别:

循证护理组

样本量:

32

Group:

Evidence-Based Care Group

Sample size:

干预措施:

采用基于循证证据的《气切患者气道全程管理方案》进行 干预

干预措施代码:

Intervention:

Intervention using the evidence-based Total Airway Management Program for Tracheotomized Patients

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

湖南 

市(区县):

长沙 

Country:

China

Province:

Hunan

City:

Changsha

单位(医院):

湖南省人民医院 

单位级别:

三甲 

Institution
hospital:

Hunan Provincial People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

气管切开带管天数

指标类型:

主要指标

Outcome:

Days of tracheotomy with tube

Type:

Primary indicator

测量时间点:

气切开始至拔管

测量方法:

观察记录

Measure time point of outcome:

Start of tracheotomy until extubation

Measure method:

Observe and record

指标中文名:

气管切开湿化天数

指标类型:

主要指标

Outcome:

Days of tracheotomy wetting

Type:

Primary indicator

测量时间点:

开始气道湿化至结束

测量方法:

观察记录

Measure time point of outcome:

Start of airway humidification to end

Measure method:

Observe and record

指标中文名:

气管切开患者机械通气天数

指标类型:

主要指标

Outcome:

Number of days of mechanical ventilation in tracheotomized patients

Type:

Primary indicator

测量时间点:

机械通气开始至结束

测量方法:

观察记录

Measure time point of outcome:

Mechanical ventilation start to end

Measure method:

Observation records

指标中文名:

患者置管相关并发症发生情况

指标类型:

主要指标

Outcome:

Occurrence of tracheotomy-related complications in patients

Type:

Primary indicator

测量时间点:

气切开始至气切结束7天

测量方法:

观察,回访,记录

Measure time point of outcome:

Start of tracheotomy to 7 days after the end of tracheotomy

Measure method:

Observe, return visit, record

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

气管切开处分泌物

组织:

Sample Name:

Secretion from tracheotomy site

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

痰液

组织:

Sample Name:

Sputum

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

试验完成后,预计2023年12月31日后6个月将数据公享于百度网盘https://pan.baidu.com/

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The data is expected to be publicly available on https://pan.baidu.com about six months after December 31, 2023

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

所有临床数据资料由专人收集,由另一人录入和分析,数据库由两人共同管理。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

All clinical data information is collected by one person, entered and analyzed by another, and the database is managed by both.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-01-10 12:03:18